(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LIPOSUC

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

LIPOSUC

ST13

US500000079330105

Class

5

Filing

79330105

Registration

7546535

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

46

Latest update

07/02/2026

Trademark type

Word

Nice classes

5

Filing date

11/30/2021

Registration date

10/29/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/29/2024

Last transaction

07/02/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

98

Owner location

FR

Examiner

ANGOTTI, SALVATORE JOHN

Law office

L80

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

BIOFAR

Representatives

Mary Margaret L. O'Donnell Blue Filament Law PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical products for enhancing energy production; anti-viral pharmaceutical preparations for enhancing energy production; medicines for enhancing energy production; pharmaceutical preparations for the treatment of the flu; cough pastilles for pharmaceutical and medical purposes; cough syrup; pharmaceutical productsparapharmaceutical products and food supplements for medical and paramedical use which may contain proteinscarbohydrateslipids and fibersmicronutrients such as vitamins and mineralsamino acids and fatty acidsin the form of individual doses such as capsuleseffervescent tablets and notsugared almondsgelatin capsulessachetschewing gumdry extracts and powders for pharmaceutical and parapharmaceutical usegranulesmicro-spherescellulose impregnated with active substancesdepuratives for enhancing energy production; pharmaceutical products made with plantsplant extracts and vegetable extracts in effervescent and other formsgranules; parapharmaceutical preparationsplant-based food supplementsplant extracts and vegetable extracts in effervescent and other forms; parapharmaceutical products used for medical purposesbased on plantsplant extractsvegetable extracts in effervescent and other forms; pharmaceutical and parapharmaceutical preparations containing minerals and vitamins in effervescent and other forms; minerals and vitamin supplements in effervescent and other forms; pharmaceutical products for phytotherapy; nutritional supplements for the nutrient intake in a normal diet; all dietetic substances adapted for medical use; nutritional supplements for medical and pharmaceutical use ready for human consumption based on food ingredients of plant and mineral origin; strengthening food substances for medical purposes; medicinal herbs; dietetic sugar for medical use; dietetic beverages adapted for medical use; medicated confectionery; food and nutritional supplements for non-medical use and meal replacements for non-medical useall these goods being made with meatmeat extractsfishpoultrygamefruit and vegetables; nutritional supplements for paramedical use as additions to the nutrient intake in a normal dietall for paramedical usedietetic substancesnutritional supplements for paramedical use prepared for human consumption based on foodstuffs of vegetable and mineral originfor strengtheningparamedical useall for paramedical use which may contain proteinscarbohydrateslipids and fibersmicronutrients such as vitamins and mineralsamino acids and fatty acidsin the form of individual doses such as capsuleseffervescent tablets and notsugared almondsgelatin capsulessachetschewing gumdry extracts and powders for pharmaceutical and parapharmaceutical usegranulesmicro-spherescellulose impregnated with active substancesdepuratives for enhancing energy production; Dietetic and dietary goodsmeal replacementsprepared meals nutritional and herbal supplementsfruitvegetablesfish and meat other than for medical use

Publications

History of USPTO decisions and trademark events.

46 publications found

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

07/02/2026

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

04/19/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

03/30/2025

FIMP

FINAL DISPOSITION PROCESSED

03/30/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

01/29/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/29/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

10/29/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/13/2024

PUBO

PUBLISHED FOR OPPOSITION

08/13/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/24/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/10/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/21/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/21/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/21/2024

RNWL

INTERNATIONAL REGISTRATION RENEWED

03/29/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/21/2024

GNRT

NON-FINAL ACTION E-MAILED

02/21/2024

CNRT

NON-FINAL ACTION WRITTEN

02/21/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/05/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/05/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/05/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/11/2023

GNRT

NON-FINAL ACTION E-MAILED

07/11/2023

CNRT

NON-FINAL ACTION WRITTEN

07/11/2023

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

06/18/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

05/31/2023

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

05/31/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/22/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/22/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/22/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

05/09/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/09/2023

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

05/09/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/09/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/09/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

05/09/2023

RFNT

REFUSAL PROCESSED BY IB

12/11/2022

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

11/21/2022

RFRR

REFUSAL PROCESSED BY MPU

11/21/2022

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

09/20/2022

CNRT

NON-FINAL ACTION WRITTEN

09/19/2022

DOCK

ASSIGNED TO EXAMINER

09/09/2022

MAFR

APPLICATION FILING RECEIPT MAILED

01/18/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/14/2022

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

01/11/2022

SDRC

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

12/30/2021

Continuous trademark protection

Get notified about every new filing that threatens LIPOSUC or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.